Chronic Pelvic Pain Treatment Market Scope, Segmentation, Development and Opportunities
Overview of Chronic Pelvic Pain Treatment Market
Pelvic pain occurs in the pelvic region (the pelvic bone or reproductive organs) in females or males. It is termed chronic when it lasts for six months or more. According to the European Association of Urology (EAU), chronic or persistent pain in structures related to the pelvis of either men or women is termed pelvic pain. Chronic pelvic pain is often associated with behavioral, negative cognitive, and emotional consequences as well as with symptoms indicative of lower urinary tract, pelvic floor, or gynecological dysfunction. Various endoscopic devices are being introduced in the market for accurate diagnosis of chronic pelvic pain. Effective management of chronic pelvic pain care and treatment in healthcare centers is expected to create significant opportunities for market players.
Generic Injectables Market Evaluation of Industry Trends, Growth Drivers
Asia Pacific held a major share of the global generic injectables market in 2020 due to presence of large number of key players, rise in demand for generic injectables, and increase in chronic diseases
Surgical Navigation Systems Market Challenges On Upcoming Trends & Growth Opportunities
The expansion of the global Surgical Navigation Systems Market is likely to be fueled by the rising incidence of target conditions such as osteoarthritis, brain tumors, and ENT problems, as well as an ageing population. As per the World Health Organization (WHO), 18% of women and 9.6% of men& have arthritis in one form or another. Osteoarthritis is a disease that primarily affects the elderly. The majority of osteoarthritis sufferers has trouble moving and is unable to conduct regular tasks.
In 2019, electromagnetic (EM) surgical navigation devices retained the greatest market share, owing to their simplicity of use, superior line of sight, and lower cost than optical navigation. Because these systems were launched before the optical as well as hybrid SNSs, they had a high penetration level. In the following years, the category is expected to maintain its prominence in the market.
Some prominent players that are found in the global surgical navigation systems market include companies such as Actelion Pharmaceuticals (Johnson & Johnson), F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., EMD Serono (Merck KGaA), Celgene Corporation, and Bayer AG
